Targeting the microenvironment of vulnerable atherosclerotic plaques: an emerging diagnosis and therapy strategy for atherosclerosis

S Zhang, Y Liu, Y Cao, S Zhang, J Sun… - Advanced …, 2022 - Wiley Online Library
Atherosclerosis is considered one of the primary causes of cardiovascular diseases (CVDs).
Unpredictable rupture of the vulnerable atherosclerotic plaques triggers adverse …

Nanotechnology in coronary heart disease

J Guo, H Wang, Y Li, S Zhu, H Hu, Z Gu - Acta Biomaterialia, 2023 - Elsevier
Coronary heart disease (CHD) is one of the major causes of death and disability worldwide,
especially in low-and middle-income countries and among older populations. Conventional …

Discrete libraries of amphiphilic poly (ethylene glycol) graft copolymers: synthesis, assembly, and bioactivity

J Chen, A Rizvi, JP Patterson… - Journal of the American …, 2022 - ACS Publications
Poly (ethylene glycol)(PEG) is an important and widely used polymer in biological and
pharmaceutical applications for minimizing nonspecific binding while improving blood …

Nanomedicine for Diagnosis and Treatment of Atherosclerosis

J Cheng, H Huang, Y Chen, R Wu - Advanced Science, 2023 - Wiley Online Library
With the changing disease spectrum, atherosclerosis has become increasingly prevalent
worldwide and the associated diseases have emerged as the leading cause of death. Due …

Chromatographic Separation: A Versatile Strategy to Prepare Discrete and Well-Defined Polymer Libraries

EA Murphy, C Zhang, CM Bates… - Accounts of Chemical …, 2024 - ACS Publications
Conspectus The preparation of discrete and well-defined polymers is an emerging strategy
for emulating the remarkable precision achieved by macromolecular synthesis in nature …

Advances in imaging and treatment of atherosclerosis based on organic nanoparticles

S Tu, W He, J Han, A Wu, W Ren - APL bioengineering, 2022 - pubs.aip.org
Atherosclerosis, a systemic chronic inflammatory disease, can lead to thrombosis and
vascular occlusion, thereby inducing a series of serious vascular diseases. Currently …

Surface-modified nanotherapeutics targeting atherosclerosis

W Li, KM Gonzalez, J Chung, M Kim, J Lu - Biomaterials science, 2022 - pubs.rsc.org
Atherosclerosis is a chronic and metabolic-related disease that is a serious threat to human
health. Currently available diagnostic and therapeutic measures for atherosclerosis lack …

[HTML][HTML] Engineering molecular nanoprobes to target early atherosclerosis: Precise diagnostic tools and promising therapeutic carriers

C Zan, J An, Z Wu, S Li - Nanotheranostics, 2023 - ncbi.nlm.nih.gov
Atherosclerosis, an inflammation-driven chronic blood vessel disease, is a major contributor
to devastating cardiovascular events, bringing serious social and economic burdens …

Uncovering atherosclerotic cardiovascular disease by PET imaging

A Maier, AJP Teunissen, SA Nauta, E Lutgens… - Nature Reviews …, 2024 - nature.com
Assessing atherosclerosis severity is essential for precise patient stratification. Specifically,
there is a need to identify patients with residual inflammation because these patients remain …

PET imaging radiotracers of chemokine receptors

SR Alluri, Y Higashi, KE Kil - Molecules, 2021 - mdpi.com
Chemokines and chemokine receptors have been recognized as critical signal components
that maintain the physiological functions of various cells, particularly the immune cells. The …